Comparative Study of Anti-Inflammatory Effect on DSS-Induced Ulcerative Colitis Between Novel Glycyrrhiza Variety and Official Compendia
Open Access
- 8 February 2021
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 11 (4), 1545
- https://doi.org/10.3390/app11041545
Abstract
Glycyrrhizae radix (GR), a plant commonly referred to as licorice, is used as a medicine and food worldwide. However, the utilization of GR from wild areas has caused desertification and a depletion of natural resources. Environmental restrictions and low productivity have limited plant cultivation. For this reason, an improved Glycyrrhiza variety, Wongam (WG), in cultivation and quality has been developed by Korea Rural Development Administration. To evaluate the equivalence of efficacy, several comparative studies between already-registered species and new cultivars have been conducted. This study evaluated the anti-inflammatory effect of WG extracts in a dextran sulfate sodium (DSS)-induced colitis model, in comparison to that of GR extracts. WG extract significantly improved the clinical signs of DSS-induced ulcerative colitis, including disease activity index, body weight loss, and colon length shortening, which was equivalent to the effect of GR. Furthermore, the fecal microbiota was analyzed by terminal restriction fragment length polymorphism. The composition of the fecal microbiota did not show a specific pattern based on experimental groups; however, a tendency toward an increase in the proportion of Lactobacillales was observed. These findings showed an equivalence of efficacy and the possible utilization of WG as a medicinal resource with already-registered species.This publication has 46 references indexed in Scilit:
- Ixeris dentataNAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in MiceEvidence-Based Complementary and Alternative Medicine, 2013
- Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acidInternational Journal of Nanomedicine, 2013
- Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancerFrontiers in Immunology, 2012
- Glycyrrhetinic acid inhibits ICAM-1 expression via blocking JNK and NF-κB pathways in TNF-α-activated endothelial cellsActa Pharmacologica Sinica, 2010
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007
- The fundamental basis of inflammatory bowel diseaseJCI Insight, 2007
- Current Therapy of Inflammatory Bowel Disease in ChildrenPediatric Drugs, 2006
- Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of ColitisThe Journal of pharmacology and experimental therapeutics, 2003
- Network of inflammatory cytokines and correlation with disease activity in ulcerative colitisThe American Journal of Gastroenterology, 1998
- Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporinDigestive Diseases and Sciences, 1993